Form 4 for VNRX VOLITIONRX LTD
Accepted 2025-11-04 00:00:00 ET · period of report 2025-11-01 · accession 0001477932-25-007898 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-04 | 2025-11-01 | VNRX | Forterre Gael | Chief Commercial Off | F - Tax | $0.43 | -1,753 | 153.8K | -1% | -$753.79 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-01 | F | D | 1,753 | $0.43 | 153,782 | D | — | — | (F1) Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 4,864 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction. |